Spot-check Assessment

Cost Savings Model from Capgemini

Capgemini, a leading supplier of global consulting and technology services, released a study showing that a typical 500 bed hospital incorporating Masimo rainbow® Pulse CO-Oximetry into its clinical standards and care pathways could generate nearly $500,000 in net annual cost savings and financial gains. Capgemini reported that significant financial benefits could be derived from incorporating noninvasive total hemoglobin (SpHb) by helping clinicians prevent unnecessary blood transfusions, identify internal bleeding, and increase patient throughput. The study concluded that "whether considered on a per-patient, department, or hospital-wide analysis, there are significant clinical and financial benefits to implementing Pulse CO-Oximetry technology."

The Capgemini whitepaper explains the study findings and cost savings calculations by care area. The Capgemini calculator allows a hospital to create customized calculations for the cost savings from SpHb monitoring by using their own inputs for surgery, intensive care, and the emergency department.

SpHb Capgemini